As expected, JOSD2 overexpression significantly promoted cell proliferation of LKB-WT NSCLC cells NCI-H1299 and PC-9, with no appreciable change in LKB-null cells A549 and NCI-H460 (Fig. 5a–d). Here, JOSD2 is linked to non-small cell lung carcinoma.